Search

Your search keyword '"Lasset, C"' showing total 236 results

Search Constraints

Start Over You searched for: "Lasset, C" Remove constraint "Lasset, C" Topic breast cancer Remove constraint Topic: breast cancer
236 results on '"Lasset, C"'

Search Results

1. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

2. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

3. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

4. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers

5. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

6. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

7. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population

8. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

9. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

10. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

11. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

12. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.

13. An interpretable deep learning model for detecting BRCA pathogenic variants of breast cancer from hematoxylin and eosin-stained pathological images.

14. Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer.

15. Role of PRMT1 and PRMT5 in Breast Cancer.

16. The Promise of Critical Biomarkers: An Optimistic Future in Breast Cancer Therapeutics.

17. Antioxidant Properties of Zinc and Copper—Blood Zinc-to Copper-Ratio as a Marker of Cancer Risk BRCA1 Mutation Carriers.

18. High Frequency of BRCA2 c.5576_5579del Carriers in Kakogawa, Japan.

19. Evaluation of Pathology Results of Patients with a History of Breast Cancer who were Operated on for Gynecological Pathologies or Prophylaxis.

20. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

21. Breast cancer prediction and categorization in the molecular era of histologic grade.

22. Predicting Quality of Life in Women with Breast Cancer Who Engage in Physical Exercise: The Role of Psychological Variables.

23. Assessing Psychological Morbidity in Cancer-Unaffected BRCA1/2 Pathogenic Variant Carriers: A Systematic Review.

24. Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

25. Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review.

26. Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.

27. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy.

28. Crosstalk of methylation and tamoxifen in breast cancer (Review).

29. Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.

30. A Review of Surgical Perspectives of Breast Cancer Genetics and Risk-Reducing Surgery.

31. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies.

32. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

33. Synchronous and metachronous bilateral breast cancer among women with a history of lobular carcinoma in situ.

34. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

35. Analysis of the Role of Continuous Early Intervention in Improving the Quality of Life of Breast Cancer Patients.

36. BARD1 mystery: tumor suppressors are cancer susceptibility genes.

37. Delineating the role of osteoprotegerin as a marker of breast cancer risk among women with a BRCA1 mutation.

38. Radiation Dose of Contrast-Enhanced Mammography: A Two-Center Prospective Comparison.

39. DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data.

40. "It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing.

41. Pregnancy after breast cancer in BRCA1/2 mutation carriers.

42. Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants.

43. Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review.

44. Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.

45. Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.

46. Serum iron status and the risk of breast cancer in the European population: a two-sample Mendelian randomisation study.

47. Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.

48. Early-onset malignant phyllodes breast tumor in a patient with germline pathogenic variants in NF1 and BRCA1 genes.

49. How does genetic testing influence anxiety, depression, and quality of life? A hereditary breast and ovarian cancer syndrome suspects trial.

50. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.

Catalog

Books, media, physical & digital resources